Kairos Pharma, Ltd.
KAPA
$0.96
$0.05265.80%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.74M | -2.01M | -1.99M | -1.81M | -890.00K |
| Total Depreciation and Amortization | 160.00K | 160.00K | 160.00K | 160.00K | 160.00K |
| Total Amortization of Deferred Charges | 180.00K | 75.00K | 66.00K | 56.00K | 40.00K |
| Total Other Non-Cash Items | 1.48M | 913.00K | 913.00K | 913.00K | -- |
| Change in Net Operating Assets | -1.17M | 883.00K | 975.00K | 764.00K | 636.00K |
| Cash from Operations | -2.09M | 25.00K | 125.00K | 81.00K | -54.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 142.00K | 102.00K | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 5.52M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -462.00K | -338.00K | -442.00K | -425.00K | -370.00K |
| Cash from Financing | 5.20M | -236.00K | -442.00K | -425.00K | -370.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.12M | -211.00K | -317.00K | -344.00K | -424.00K |